Localization and Function of Cannabinoid Receptors in the Corpus Cavernosum

Basis for Modulation of Nitric Oxide Synthase Nerve Activity

Christian Gratzke, George J. Christ, Christian G. Stief, Karl Erik Andersson, Petter Hedlund

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: Anandamide, a proposed endogenous cannabinoid (CB) agonist, has been shown to enhance neurogenic responses in vitro of the rat corpus cavernosal tissue (CC). However, no information is available on the distribution of CB-receptors or effects by anandamide in CC from primates or humans. Objective: To characterize the distribution of CB-receptor isoforms in the human and primate CC and to investigate the effects of anandamide on isolated CC preparations. Design, setting, and participants: CC tissue was excised from the crura penis of six rhesus monkeys and five patients. Expression and distribution of CB1 and CB2 receptors were characterized with Western blot analyses and immunohistochemical investigations. The effects of anandamide on isolated CC preparations were analyzed during pharmacologic and nerve-mediated activation of primate tissue in aerated organ baths. Measurements: The expression and localization of CB1 and CB2 receptors in the primate CC and effects of anandamide on nerve-mediated relaxations and pharmacologically evoked contractions. Results and limitations: Western blot experiments revealed CB1 and CB2 receptors at expected band weights. Within and between strands of CC smooth muscle, CB1 and CB2 immunoreactivity (IR) was found in nerve fibers that also expressed IR for nitric oxide synthase (NOS) or transient receptor potential V1 (TRPV1). Neither CB1-IR nor CB2-IR nerves were colocalized with calcitonin-gene-related peptide (CGRP)-containing or tyrosine hydroxylase-containing nerves. No differences were observed between primate and human CC sections. Anandamide (10-9 to 10-4 M) had no contractile effects on CC smooth muscle, no relaxant effects on precontracted preparations, and no effect on phenylephrine-induced contractions. However, anandamide (10 μM) inhibited electrically evoked smooth-muscle relaxations (34-48%; p ≤ 0.05). Conclusions: CB1 and CB2 receptors are located on NOS-containing nerves in primate and human CC tissue. In contrast to findings in rats, anandamide antagonized nerve-mediated relaxations of the primate CC, suggesting important species differences for CB-mediated functions. The results also suggest a peripheral mechanism for cannabis-related sexual dysfunction.

Original languageEnglish
Pages (from-to)342-349
Number of pages8
JournalEuropean Urology
Volume57
Issue number2
DOIs
Publication statusPublished - Feb 2010

Fingerprint

Cannabinoid Receptors
Nitric Oxide Synthase
Primates
Cannabinoid Receptor CB2
Cannabinoid Receptor CB1
Smooth Muscle
Western Blotting
Cannabinoid Receptor Agonists
Vasopressin Receptors
Muscle Relaxation
Cannabinoids
anandamide
Calcitonin Gene-Related Peptide
Penis
Tyrosine 3-Monooxygenase
Phenylephrine
Cannabis
Macaca mulatta
Baths
Nerve Fibers

Keywords

  • Anandamide
  • CB1
  • CB2
  • Human
  • Monkey
  • Nerve
  • Penis
  • Relaxation
  • TRPV1

ASJC Scopus subject areas

  • Urology

Cite this

Localization and Function of Cannabinoid Receptors in the Corpus Cavernosum : Basis for Modulation of Nitric Oxide Synthase Nerve Activity. / Gratzke, Christian; Christ, George J.; Stief, Christian G.; Andersson, Karl Erik; Hedlund, Petter.

In: European Urology, Vol. 57, No. 2, 02.2010, p. 342-349.

Research output: Contribution to journalArticle

Gratzke, Christian ; Christ, George J. ; Stief, Christian G. ; Andersson, Karl Erik ; Hedlund, Petter. / Localization and Function of Cannabinoid Receptors in the Corpus Cavernosum : Basis for Modulation of Nitric Oxide Synthase Nerve Activity. In: European Urology. 2010 ; Vol. 57, No. 2. pp. 342-349.
@article{3f0c443f3bda487dac1ef1791b713973,
title = "Localization and Function of Cannabinoid Receptors in the Corpus Cavernosum: Basis for Modulation of Nitric Oxide Synthase Nerve Activity",
abstract = "Background: Anandamide, a proposed endogenous cannabinoid (CB) agonist, has been shown to enhance neurogenic responses in vitro of the rat corpus cavernosal tissue (CC). However, no information is available on the distribution of CB-receptors or effects by anandamide in CC from primates or humans. Objective: To characterize the distribution of CB-receptor isoforms in the human and primate CC and to investigate the effects of anandamide on isolated CC preparations. Design, setting, and participants: CC tissue was excised from the crura penis of six rhesus monkeys and five patients. Expression and distribution of CB1 and CB2 receptors were characterized with Western blot analyses and immunohistochemical investigations. The effects of anandamide on isolated CC preparations were analyzed during pharmacologic and nerve-mediated activation of primate tissue in aerated organ baths. Measurements: The expression and localization of CB1 and CB2 receptors in the primate CC and effects of anandamide on nerve-mediated relaxations and pharmacologically evoked contractions. Results and limitations: Western blot experiments revealed CB1 and CB2 receptors at expected band weights. Within and between strands of CC smooth muscle, CB1 and CB2 immunoreactivity (IR) was found in nerve fibers that also expressed IR for nitric oxide synthase (NOS) or transient receptor potential V1 (TRPV1). Neither CB1-IR nor CB2-IR nerves were colocalized with calcitonin-gene-related peptide (CGRP)-containing or tyrosine hydroxylase-containing nerves. No differences were observed between primate and human CC sections. Anandamide (10-9 to 10-4 M) had no contractile effects on CC smooth muscle, no relaxant effects on precontracted preparations, and no effect on phenylephrine-induced contractions. However, anandamide (10 μM) inhibited electrically evoked smooth-muscle relaxations (34-48{\%}; p ≤ 0.05). Conclusions: CB1 and CB2 receptors are located on NOS-containing nerves in primate and human CC tissue. In contrast to findings in rats, anandamide antagonized nerve-mediated relaxations of the primate CC, suggesting important species differences for CB-mediated functions. The results also suggest a peripheral mechanism for cannabis-related sexual dysfunction.",
keywords = "Anandamide, CB1, CB2, Human, Monkey, Nerve, Penis, Relaxation, TRPV1",
author = "Christian Gratzke and Christ, {George J.} and Stief, {Christian G.} and Andersson, {Karl Erik} and Petter Hedlund",
year = "2010",
month = "2",
doi = "10.1016/j.eururo.2008.12.024",
language = "English",
volume = "57",
pages = "342--349",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier B.V.",
number = "2",

}

TY - JOUR

T1 - Localization and Function of Cannabinoid Receptors in the Corpus Cavernosum

T2 - Basis for Modulation of Nitric Oxide Synthase Nerve Activity

AU - Gratzke, Christian

AU - Christ, George J.

AU - Stief, Christian G.

AU - Andersson, Karl Erik

AU - Hedlund, Petter

PY - 2010/2

Y1 - 2010/2

N2 - Background: Anandamide, a proposed endogenous cannabinoid (CB) agonist, has been shown to enhance neurogenic responses in vitro of the rat corpus cavernosal tissue (CC). However, no information is available on the distribution of CB-receptors or effects by anandamide in CC from primates or humans. Objective: To characterize the distribution of CB-receptor isoforms in the human and primate CC and to investigate the effects of anandamide on isolated CC preparations. Design, setting, and participants: CC tissue was excised from the crura penis of six rhesus monkeys and five patients. Expression and distribution of CB1 and CB2 receptors were characterized with Western blot analyses and immunohistochemical investigations. The effects of anandamide on isolated CC preparations were analyzed during pharmacologic and nerve-mediated activation of primate tissue in aerated organ baths. Measurements: The expression and localization of CB1 and CB2 receptors in the primate CC and effects of anandamide on nerve-mediated relaxations and pharmacologically evoked contractions. Results and limitations: Western blot experiments revealed CB1 and CB2 receptors at expected band weights. Within and between strands of CC smooth muscle, CB1 and CB2 immunoreactivity (IR) was found in nerve fibers that also expressed IR for nitric oxide synthase (NOS) or transient receptor potential V1 (TRPV1). Neither CB1-IR nor CB2-IR nerves were colocalized with calcitonin-gene-related peptide (CGRP)-containing or tyrosine hydroxylase-containing nerves. No differences were observed between primate and human CC sections. Anandamide (10-9 to 10-4 M) had no contractile effects on CC smooth muscle, no relaxant effects on precontracted preparations, and no effect on phenylephrine-induced contractions. However, anandamide (10 μM) inhibited electrically evoked smooth-muscle relaxations (34-48%; p ≤ 0.05). Conclusions: CB1 and CB2 receptors are located on NOS-containing nerves in primate and human CC tissue. In contrast to findings in rats, anandamide antagonized nerve-mediated relaxations of the primate CC, suggesting important species differences for CB-mediated functions. The results also suggest a peripheral mechanism for cannabis-related sexual dysfunction.

AB - Background: Anandamide, a proposed endogenous cannabinoid (CB) agonist, has been shown to enhance neurogenic responses in vitro of the rat corpus cavernosal tissue (CC). However, no information is available on the distribution of CB-receptors or effects by anandamide in CC from primates or humans. Objective: To characterize the distribution of CB-receptor isoforms in the human and primate CC and to investigate the effects of anandamide on isolated CC preparations. Design, setting, and participants: CC tissue was excised from the crura penis of six rhesus monkeys and five patients. Expression and distribution of CB1 and CB2 receptors were characterized with Western blot analyses and immunohistochemical investigations. The effects of anandamide on isolated CC preparations were analyzed during pharmacologic and nerve-mediated activation of primate tissue in aerated organ baths. Measurements: The expression and localization of CB1 and CB2 receptors in the primate CC and effects of anandamide on nerve-mediated relaxations and pharmacologically evoked contractions. Results and limitations: Western blot experiments revealed CB1 and CB2 receptors at expected band weights. Within and between strands of CC smooth muscle, CB1 and CB2 immunoreactivity (IR) was found in nerve fibers that also expressed IR for nitric oxide synthase (NOS) or transient receptor potential V1 (TRPV1). Neither CB1-IR nor CB2-IR nerves were colocalized with calcitonin-gene-related peptide (CGRP)-containing or tyrosine hydroxylase-containing nerves. No differences were observed between primate and human CC sections. Anandamide (10-9 to 10-4 M) had no contractile effects on CC smooth muscle, no relaxant effects on precontracted preparations, and no effect on phenylephrine-induced contractions. However, anandamide (10 μM) inhibited electrically evoked smooth-muscle relaxations (34-48%; p ≤ 0.05). Conclusions: CB1 and CB2 receptors are located on NOS-containing nerves in primate and human CC tissue. In contrast to findings in rats, anandamide antagonized nerve-mediated relaxations of the primate CC, suggesting important species differences for CB-mediated functions. The results also suggest a peripheral mechanism for cannabis-related sexual dysfunction.

KW - Anandamide

KW - CB1

KW - CB2

KW - Human

KW - Monkey

KW - Nerve

KW - Penis

KW - Relaxation

KW - TRPV1

UR - http://www.scopus.com/inward/record.url?scp=72149121295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72149121295&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2008.12.024

DO - 10.1016/j.eururo.2008.12.024

M3 - Article

VL - 57

SP - 342

EP - 349

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 2

ER -